Rehm, Jana http://orcid.org/0009-0002-2960-1996
Winzer, Robert
Notni, Johannes
Hempel, Sebastian
Distler, Marius
Folprecht, Gunnar
Kotzerke, Jörg
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 8 March 2024
Accepted: 1 May 2024
First Online: 21 May 2024
Declarations
:
: The data analysis received approval from the responsible local ethics committees (EK-242052023).
: The authors affirm that the patient provided written informed consent prior to the investigation.
: The authors affirm that the patient provided written informed consent for publication of the images.
: Johannes Notni: co-inventor of patents related to <sup>68</sup>Ga-Trivehexin; co-founder, shareholder, and CSO of TRIMT GmbH (Radeberg, Germany); member of the scientific advisory board of Radiopharm Theranostics LLC (Carlton, Australia). All other authors declare that they have no competing interests.